EcAMSat investigated spaceflight effects on bacterial antibiotic resistance and its genetic basis. Bacterial antibiotic resistance may pose a danger to astronauts in microgravity, where the immune response is weakened. Scientists believe that the results of this experiment could help design effective countermeasures to protect astronauts’ health during long-duration human space missions.
EcAMSat achieved full mission success on December 12, 2017, following the successful execution of the flight and ground control experiments. Publications are in progress. Results will be available upon publicationses.
|Mission||Launch/Start Date||Landing/End Date||Duration|